Literature DB >> 6327741

Alterations in the transport and processing of Rous sarcoma virus envelope glycoproteins mutated in the signal and anchor regions.

J W Wills, J M Hardwick, K Shaw, E Hunter.   

Abstract

The env gene of Rous sarcoma virus codes for two glycoproteins which are located on the surface of infectious virions. Subcloning of these coding sequences in the place of the late region of SV40 DNA has allowed the expression of a normally glycosylated, functionally active glycoprotein complex on the surface of monkey cells. Through the use of site-directed mutagenesis, the role of specific amino acids in the signal peptide, signal peptidase cleavage site, and membrane anchor region have been investigated. Amino-terminal mutations have shown that deletion of the signal peptidase cleavage site along with one or two amino acids of the hydrophobic signal peptide results in the synthesis of an unglycosylated, uncleaved, and presumably cytoplasmically located precursor. Nevertheless, changing the signal peptidase cleavage site from ala/asp to ala/asn does not block the translocation of the glycoprotein across the membrane or the action of the peptidase. At the other end of the molecule, carboxy-terminal mutations have shown that the deletion of the hydrophobic membrane anchor region is not sufficient for the secretion of the truncated glycoprotein. Interpretations of these results based on recent models for protein transport and secretion are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6327741     DOI: 10.1002/jcb.240230109

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.

Authors:  J Dong; M G Roth; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Functional tolerance of the human immunodeficiency virus type 1 envelope signal peptide to mutations in the amino-terminal and hydrophobic regions.

Authors:  H Ellerbrok; L D'Auriol; C Vaquero; M Sitbon
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.

Authors:  L G Perez; G L Davis; E Hunter
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  An amino-terminal deletion mutation of pseudorabies virus glycoprotein gIII affects protein localization and RNA accumulation.

Authors:  L W Enquist; C L Keeler; A K Robbins; J P Ryan; M E Whealy
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Proviral insertional activation of c-erbB: differential processing of the protein products arising from two alternate transcripts.

Authors:  N J Maihle; M A Raines; T W Flickinger; H J Kung
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

7.  A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication.

Authors:  R A Katz; A M Skalka
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

8.  cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control.

Authors:  R A Katz; M Kotler; A M Skalka
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Expression of the Rous sarcoma virus env gene from a simian virus 40 late-region replacement vector: effects of upstream initiation codons.

Authors:  L Perez; J W Wills; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

10.  Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells.

Authors:  J W Wills; R C Craven; J A Achacoso
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.